We join BRECISE, a major cancer research initiative advancing biomarker development to improve diagnosis, treatment and personalized care across Europe.
BC Platforms deepens its partnership with the University of Nottingham and NUH, supporting secure data sharing and TRE-driven insights in diseases such as cancer and diabetes.
BC Platforms and NTT Life Science Corporation form an exclusive collaboration to drive data-driven medicine and strengthen Real-World Data capabilities worldwide.
BC Platforms partners with HUS on ONCOVALUE, a Horizon Europe project creating an AI framework to turn clinical data into Real-World Evidence for cancer treatment decisions.